155 related articles for article (PubMed ID: 37981080)
21. The role of long non-coding RNAs in drug resistance of cancer.
Zhang HD; Jiang LH; Zhong SL; Li J; Sun DW; Hou JC; Wang DD; Zhou SY; Tang JH
Clin Genet; 2021 Jan; 99(1):84-92. PubMed ID: 32583420
[TBL] [Abstract][Full Text] [Related]
22. Five key lncRNAs considered as prognostic targets for predicting pancreatic ductal adenocarcinoma.
Song J; Xu Q; Zhang H; Yin X; Zhu C; Zhao K; Zhu J
J Cell Biochem; 2018 Jun; 119(6):4559-4569. PubMed ID: 29239017
[TBL] [Abstract][Full Text] [Related]
23. LncRNA PVT1 triggers Cyto-protective autophagy and promotes pancreatic ductal adenocarcinoma development via the miR-20a-5p/ULK1 Axis.
Huang F; Chen W; Peng J; Li Y; Zhuang Y; Zhu Z; Shao C; Yang W; Yao H; Zhang S
Mol Cancer; 2018 Jul; 17(1):98. PubMed ID: 30001707
[TBL] [Abstract][Full Text] [Related]
24. LncRNA as a multifunctional regulator in cancer multi-drug resistance.
He J; Zhu S; Liang X; Zhang Q; Luo X; Liu C; Song L
Mol Biol Rep; 2021 Aug; 48(8):1-15. PubMed ID: 34333735
[TBL] [Abstract][Full Text] [Related]
25. Long noncoding RNAs: role and contribution in pancreatic cancer.
Ramya Devi KT; Karthik D; Mahendran T; Jaganathan MK; Hemdev SP
Transcription; 2021 Feb; 12(1):12-27. PubMed ID: 34036896
[TBL] [Abstract][Full Text] [Related]
26. Non-coding RNA in drug resistance of hepatocellular carcinoma.
Ding B; Lou W; Xu L; Fan W
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30224380
[TBL] [Abstract][Full Text] [Related]
27. Long non-coding RNAs expressed in pancreatic ductal adenocarcinoma and lncRNA BC008363 an independent prognostic factor in PDAC.
Li J; Liu D; Hua R; Zhang J; Liu W; Huo Y; Cheng Y; Hong J; Sun Y
Pancreatology; 2014; 14(5):385-90. PubMed ID: 25200694
[TBL] [Abstract][Full Text] [Related]
28. Noncoding RNAs in drug-resistant pancreatic cancer: A review.
Lin Z; Lu S; Xie X; Yi X; Huang H
Biomed Pharmacother; 2020 Nov; 131():110768. PubMed ID: 33152930
[TBL] [Abstract][Full Text] [Related]
29. LncRNA-PVT1 promotes pancreatic cancer cells proliferation and migration through acting as a molecular sponge to regulate miR-448.
Zhao L; Kong H; Sun H; Chen Z; Chen B; Zhou M
J Cell Physiol; 2018 May; 233(5):4044-4055. PubMed ID: 28657147
[TBL] [Abstract][Full Text] [Related]
30. Emerging role of long non-coding RNAs in cancer chemoresistance: unravelling the multifaceted role and prospective therapeutic targeting.
Singh D; Khan MA; Siddique HR
Mol Biol Rep; 2020 Jul; 47(7):5569-5585. PubMed ID: 32601922
[TBL] [Abstract][Full Text] [Related]
31. Gemcitabine exhibits a suppressive effect on pancreatic cancer cell growth by regulating processing of PVT1 to miR1207.
You L; Wang H; Yang G; Zhao F; Zhang J; Liu Z; Zhang T; Liang Z; Liu C; Zhao Y
Mol Oncol; 2018 Dec; 12(12):2147-2164. PubMed ID: 30341811
[TBL] [Abstract][Full Text] [Related]
32. The role of long non-coding RNA AFAP1-AS1 in human malignant tumors.
Ji D; Zhong X; Jiang X; Leng K; Xu Y; Li Z; Huang L; Li J; Cui Y
Pathol Res Pract; 2018 Oct; 214(10):1524-1531. PubMed ID: 30173945
[TBL] [Abstract][Full Text] [Related]
33. Long noncoding RNA LEF1-AS1 acts as a microRNA-10a-5p regulator to enhance MSI1 expression and promote chemoresistance in hepatocellular carcinoma cells through activating AKT signaling pathway.
Gao J; Dai C; Yu X; Yin XB; Zhou F
J Cell Biochem; 2021 Jan; 122(1):86-99. PubMed ID: 32786108
[TBL] [Abstract][Full Text] [Related]
34. Analysis of long non-coding RNA expression profiles in pancreatic ductal adenocarcinoma.
Fu XL; Liu DJ; Yan TT; Yang JY; Yang MW; Li J; Huo YM; Liu W; Zhang JF; Hong J; Hua R; Chen HY; Sun YW
Sci Rep; 2016 Sep; 6():33535. PubMed ID: 27628540
[TBL] [Abstract][Full Text] [Related]
35. Long non-coding RNAs in anti-cancer drug resistance.
Chen QN; Wei CC; Wang ZX; Sun M
Oncotarget; 2017 Jan; 8(1):1925-1936. PubMed ID: 27713133
[TBL] [Abstract][Full Text] [Related]
36. Long non-coding RNA MEG3 functions as a tumour suppressor and has prognostic predictive value in human pancreatic cancer.
Ma L; Wang F; Du C; Zhang Z; Guo H; Xie X; Gao H; Zhuang Y; Kornmann M; Gao H; Tian X; Yang Y
Oncol Rep; 2018 Mar; 39(3):1132-1140. PubMed ID: 29328401
[TBL] [Abstract][Full Text] [Related]
37. lncRNA
Li N; Yang G; Luo L; Ling L; Wang X; Shi L; Lan J; Jia X; Zhang Q; Long Z; Liu J; Hu W; He Z; Liu H; Liu W; Zheng G
Clin Cancer Res; 2020 Apr; 26(7):1736-1748. PubMed ID: 31831555
[TBL] [Abstract][Full Text] [Related]
38. microRNA-301b-3p downregulation underlies a novel inhibitory role of long non-coding RNA MBNL1-AS1 in non-small cell lung cancer.
Li P; Xing W; Xu J; Yuan D; Liang G; Liu B; Ma H
Stem Cell Res Ther; 2019 May; 10(1):144. PubMed ID: 31113460
[TBL] [Abstract][Full Text] [Related]
39. LncRNA DDX11-AS1 Promotes Chemoresistance through LIN28A-Mediated ATG12 mRNA Stabilization in Breast Cancer.
Si X; Zhang G; Li M; Yao M; Shi X; Dong Z; Gao S
Pharmacology; 2023; 108(1):61-73. PubMed ID: 36382664
[TBL] [Abstract][Full Text] [Related]
40. Long Noncoding RNA LINC00460 Promotes the Gefitinib Resistance of Nonsmall Cell Lung Cancer Through Epidermal Growth Factor Receptor by Sponging miR-769-5p.
Ma G; Zhu J; Liu F; Yang Y
DNA Cell Biol; 2019 Feb; 38(2):176-183. PubMed ID: 30601026
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
